Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

Literature DB >> 15472367

Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

A M Freydiere¹, J D Perry, O Faure, B Willinger, A M Tortorano, A Nicholson, J Peman, P E Verweij.

Abstract

When evaluated in six clinical laboratories from six countries with 1,174 fresh isolates, including 715 Candida glabrata and 459 non-C. glabrata strains, GLABRATA RTT (Fumouze Diagnostics, Levallois Perret, France) yielded an overall sensitivity and an overall specificity of 95.8 and 98.9%, respectively. The results were consistent from one laboratory to another. The five false-positive results corresponded to C. parapsilosis (n = 2), C. tropicalis, C. guilliermondii, and C. lusitaniae. GLABRATA RTT allows a rapid, cost-effective, and reliable presumptive identification of C. glabrata.

Entities: Species

Mesh：

Substances：

Year: 2004 PMID： 15472367 PMCID： PMC522330 DOI： 10.1128/JCM.42.10.4870-4872.2004

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

21 in total

1. Rapid identification of Candida species by confocal Raman microspectroscopy.

Authors: K Maquelin; L P Choo-Smith; H P Endtz; H A Bruining; G J Puppels
Journal: J Clin Microbiol Date: 2002-02 Impact factor: 5.948

Review 2. Yeast identification in the clinical microbiology laboratory: phenotypical methods.

Authors: A M Freydiere; R Guinet; P Boiron
Journal: Med Mycol Date: 2001-02 Impact factor: 4.076

3. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death.

Authors: A Viudes; J Pemán; E Cantón; P Ubeda; J L López-Ribot; M Gobernado
Journal: Eur J Clin Microbiol Infect Dis Date: 2002-10-31 Impact factor: 3.267

4. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors: M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal: Antimicrob Agents Chemother Date: 2000-03 Impact factor: 5.191

5. Performance of candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida.

Authors: B Willinger; C Hillowoth; B Selitsch; M Manafi
Journal: J Clin Microbiol Date: 2001-10 Impact factor: 5.948

6. Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species.

Authors: H Fricker-Hidalgo; S Orenga; B Lebeau; H Pelloux; M P Brenier-Pinchart; P Ambroise-Thomas; R Grillot
Journal: J Clin Microbiol Date: 2001-04 Impact factor: 5.948

7. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.

Authors: A L Colombo; J Perfect; M DiNubile; K Bartizal; M Motyl; P Hicks; R Lupinacci; C Sable; N Kartsonis
Journal: Eur J Clin Microbiol Infect Dis Date: 2003-07-23 Impact factor: 3.267

8. Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories.

Authors: M A Piens; J D Perry; H Raberin; F Parant; A M Freydière
Journal: J Clin Pathol Date: 2003-09 Impact factor: 3.411

3. Evaluation of the commercial rapid trehalose test (GLABRATA RTT) for the point of isolation identification of Candida glabrata isolates in primary cultures.

Authors: Mark Fraser; Andrew M Borman; Elizabeth M Johnson
Journal: Mycopathologia Date: 2012-01-11 Impact factor: 2.574

Review 4. [Diagnosing fungal infections: trends and new developments].

Authors: Birgit Willinger
Journal: Wien Med Wochenschr Date: 2007

4 in total